Moreover, ICC exhibits unique mutation enrichments, such as IDH1/2 mutation, NTRK gene fusions, FGFR2 fusions/rearrangements, and RET fusions, particularly IDH1 mutations, which have higher mutation frequencies than other tumor types [85]. The gene discussed is FGFR2; the disease is intrahepatic cholangiocarcinoma.